← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2010Last known activity
Feb 12, 2019
Acquired by Ayala Pharmaceuticals, Inc, on Jan 3, 2023
Timeline
2000s
- Jun 1, 2002
Advaxis, Inc.— Founded
2020s
- Jan 3, 2023
Ayala Pharmaceuticals, Inc,— Acquired By
Drugs by trial phase (9 distinct, 13 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Anus Neoplasms
- Carcinoma
- Carcinoma, Adenosquamous
- Carcinoma in Situ
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Small Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Cervical Intraepithelial Neoplasia
- Head and Neck Neoplasms
- Lung Neoplasms
- Neoplasms
- Oropharyngeal Neoplasms
- Prostatic Neoplasms
- Small Cell Lung Carcinoma
- Squamous Cell Carcinoma of Head and Neck
- Uterine Cervical Neoplasms
Recent trials (15)
- NCT03847519Study directorPhase 1/Phase 2Feb 12, 2019
- NCT03847519Lead sponsorPhase 1/Phase 2Feb 12, 2019
- NCT03265080Lead sponsorPhase 1Mar 31, 2018
- NCT03265080Study directorPhase 1Mar 31, 2018
- NCT02531854Lead sponsorPhase 2Dec 1, 2016
- NCT02853604Lead sponsorPhase 3Sep 1, 2016
- NCT02386501Lead sponsorPhase 1/Phase 2Sep 1, 2015
- NCT02399813Lead sponsorPhase 2Sep 1, 2015
- NCT02291055Lead sponsorPhase 1/Phase 2Apr 1, 2015
- NCT02325557Lead sponsorPhase 1/Phase 2Jan 1, 2015
- NCT02164461Lead sponsorPhase 1/Phase 2Jan 1, 2015
- NCT02002182CollaboratorPhase 2Dec 1, 2013
- NCT01598792CollaboratorPhase 1Feb 1, 2012
- NCT01266460CollaboratorPhase 2May 1, 2011
- NCT01116245Lead sponsorPhase 2Apr 1, 2010
Details
- Founded
- Princeton, NJ, US Jun 1, 2002
- Last known activity
- Feb 12, 2019